A detailed history of Norden Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Norden Group LLC holds 8,660 shares of ABBV stock, worth $1.68 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
8,660
Previous 8,149 6.27%
Holding current value
$1.68 Million
Previous $1.48 Billion 0.08%
% of portfolio
0.3%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $79,097 - $92,368
511 Added 6.27%
8,660 $1.49 Billion
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $21 Million - $23.9 Million
-131,438 Reduced 94.16%
8,149 $1.48 Billion
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $21.3 Million - $24.2 Million
133,110 Added 2055.12%
139,587 $25.4 Billion
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $270,796 - $304,980
-1,968 Reduced 23.3%
6,477 $1 Billion
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $1.13 Million - $1.31 Million
8,445 New
8,445 $1.26 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.